SEO Version
STATEMENT OF
CORPORATE GOVERNANCE
ASIAMEDIC LIMITED
ANNUAL REPORT 2013
26
Whistle-Blowing
The Company has in place a whistle-blowing policy which is published in the handbook of human resources department.
The handbook clearly defines the scope of the whistle-blowing and sets out the procedures for raising concern or
making a complaint and the process of investigation and dealing with the outcome of the investigation.
Employees are free to bring complaints to the attention of their supervisors or General Manager, the Human Resources
manager or CEO, as they would in any other workplace concern. The recipient of such complaints shall forward them
promptly to the ARMC Chairman. The ARMC will treat all information received confidentially and protect the identity
of all whistle-blowers. The employee can choose to send the complaint directly to the ARMC Chairman. Following
investigation and evaluation of a complaint, the ARMC Chairman shall report to the ARMC on recommended disciplinary
or remedial action, if any. The action determined by the ARMC to be appropriated shall then be brought to the Board
or to appropriate members of senior management for authorization and implementation respectively.
The policy is communicated to all employees as part of the Company’s efforts to promote awareness of fraud control.
SHAREHOLDER RIGHTS, COMMUNICATION WITH SHAREHOLDERS AND CONDUCT OF
SHAREHOLDER MEETINGS
Principle 14: Companies should treat all shareholders fairly and equitably, and should recognise, protect
and facilitate the exercise of shareholders’ rights, and continually review and update such governance
arrangements.
Principle 15: Companies should actively engage their shareholders and put in place an investor relations
policy to promote regular, effective and fair communication with shareholders.
Principle 16: Companies should encourage greater shareholder participation at general meetings of
shareholders, and allow shareholders the opportunity to communicate their views on various matters
affecting the company.
In line with the continuous obligations of the Company pursuant to the Catalist Rules, the Board’s policy is that all
shareholders be informed of all major developments that impact the Group.
Information is disseminated to shareholders on a timely basis through:
(a)
SGXNET announcements and news releases;
(b)
Annual Report prepared and issued to all shareholders;
(c)
press releases on major developments of the Group;
(d)
notices of and explanatory notes for the AGMs and extraordinary general meetings (“EGMs”); and
(e)
the Company’s website at www.asiamedic.com.sg, where shareholders can access information on the Group.
Powered by FlippingBook Publisher